Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014 - 2025

NEW YORK, April 26, 2017 /PRNewswire/ -- With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market.


Read the full report: http://www.reportlinker.com/p04838565/Mycoplasma-Testing-Market-Analysis-By-Product-By-Technology-PCR-ELISA-Direct-Assay-Microbial-Culture-Techniques-By-Application-Cell-Line-Virus-End-of-Production-Cells-Testing-By-End-use-And-Segment-Forecasts.html



Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth.

Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products.

Further Key Findings From the Study Suggest:
- In 2016, kits & reagents dominated the market and is also expected to show highest CAGR over the forecast period owing to its wider application in mycoplasma tests
- Amongst the technology segment, Polymerase Chain Reaction (PCR) held the largest share in 2016 owing to the delivery of fast & accurate results associated with this technology
- Cell line testing is anticipated to exhibit highest CAGR over the forecast period due to the increasing risk of cell line contamination
- In 2016, pharmaceutical and biotechnology companies accounted for the largest market share due to rising number of research activities in drug discovery and development
- North America dominated the market in 2016 owing to rising healthcare spending levels and government funding for life science-related research

Read the full report: http://www.reportlinker.com/p04838565/Mycoplasma-Testing-Market-Analysis-By-Product-By-Technology-PCR-ELISA-Direct-Assay-Microbial-Culture-Techniques-By-Application-Cell-Line-Virus-End-of-Production-Cells-Testing-By-End-use-And-Segment-Forecasts.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com